# REGENXBIO Inc.: filings

RGNX · Nasdaq · CIK 1590877 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rgnx.md) · [Financials](/companies/rgnx/financials.md) · [Filings](/companies/rgnx/filings.md) · [Insiders](/companies/rgnx/insiders.md)

## Reports and events: 180 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 400, 8-K 117, SC 13G/A 38, 10-Q 33, 3 26, 144 15, 424B5 13, SC 13G 13, S-8 12, 10-K 11, DEF 14A 11, DEFA14A 11, CORRESP 7, CT ORDER 5, EFFECT 5, 425 4, 4/A 4, ARS 4, S-3 4, SCHEDULE 13G/A 4, SEC STAFF LETTER 4, D 3, S-1/A 3, S-3ASR 3, UPLOAD 3, FWP 2, PRE 14A 2, SC TO-I/A 2, 10-Q/A 1, 424B3 1, 424B4 1, 5 1, 8-A12B 1, 8-K/A 1, CERTNAS 1, DRS 1, DRS/A 1, DRSLTR 1, POS AM 1, POSASR 1, RW 1, S-1 1, S-1MEF 1, S-3/A 1, SC 13D 1, SC 13D/A 1, SCHEDULE 13G 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 11:00 ET | [8-K](/filings/0001193125-26-423376.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-423376 |
| 2026-09-23 | 20:05 ET | [8-K](/filings/0001193125-26-399377.md) | 1.01 Entry into a material agreement | 0001193125-26-399377 |
| 2026-08-25 | 20:57 ET | [8-K](/filings/0001193125-26-365287.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-365287 |
| 2026-08-24 | 21:20 ET | [8-K](/filings/0001193125-26-363786.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-363786 |
| 2026-08-06 | 11:15 ET | [10-Q](/filings/0001193125-26-336725.md) | Quarterly report, period 2026-06-30 | 0001193125-26-336725 |
| 2026-08-06 | 11:10 ET | [8-K](/filings/0001193125-26-336716.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336716 |
| 2026-07-20 | 11:34 ET | [8-K](/filings/0001193125-26-308342.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-308342 |
| 2026-06-29 | 11:15 ET | [8-K](/filings/0001193125-26-286825.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-286825 |
| 2026-06-03 | 11:30 ET | [8-K](/filings/0001193125-26-254590.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-26-254590 |
| 2026-05-14 | 11:30 ET | [10-Q](/filings/0001193125-26-222804.md) | Quarterly report, period 2026-03-31 | 0001193125-26-222804 |
| 2026-05-14 | 11:15 ET | [8-K](/filings/0001193125-26-222768.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-222768 |
| 2026-04-14 | 21:00 ET | [DEF 14A](/filings/0001193125-26-155058.md) | Proxy statement, period 2026-05-29 | 0001193125-26-155058 |
| 2026-03-20 | 21:15 ET | [8-K](/filings/0001193125-26-117913.md) | 1.01 Entry into a material agreement | 0001193125-26-117913 |
| 2026-03-05 | 21:21 ET | [10-K](/filings/0001193125-26-094013.md) | Annual report, period 2025-12-31 | 0001193125-26-094013 |
| 2026-03-05 | 12:30 ET | [8-K](/filings/0001193125-26-092566.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-092566 |
| 2026-02-10 | 02:44 ET | [8-K](/filings/0001193125-26-043342.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-043342 |
| 2026-01-28 | 13:30 ET | [8-K](/filings/0001193125-26-026139.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-026139 |
| 2025-11-06 | 12:38 ET | [8-K](/filings/0001193125-25-268101.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268101 |
| 2025-11-06 | 12:30 ET | [10-Q](/filings/0001193125-25-268095.md) | Quarterly report, period 2025-09-30 | 0001193125-25-268095 |
| 2025-08-18 | 21:10 ET | [8-K](/filings/0000950170-25-109829.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-109829 |
| 2025-08-07 | 11:30 ET | [10-Q](/filings/0001193125-25-174953.md) | Quarterly report, period 2025-06-30 | 0001193125-25-174953 |
| 2025-08-07 | 11:15 ET | [8-K](/filings/0001193125-25-174947.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-174947 |
| 2025-06-03 | 20:30 ET | [8-K](/filings/0000950170-25-080986.md) | 5.07 Shareholder vote results | 0000950170-25-080986 |
| 2025-05-19 | 20:15 ET | [8-K](/filings/0001193125-25-122456.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-122456 |
| 2025-05-12 | 20:15 ET | [10-Q](/filings/0000950170-25-069237.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069237 |
| 2025-05-12 | 20:11 ET | [8-K](/filings/0000950170-25-069211.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069211 |
| 2025-04-08 | 20:15 ET | [DEF 14A](/filings/0000950170-25-052069.md) | Proxy statement, period 2025-05-30 | 0000950170-25-052069 |
| 2025-03-13 | 20:20 ET | [10-K](/filings/0000950170-25-038770.md) | Annual report, period 2024-12-31 | 0000950170-25-038770 |
| 2025-03-13 | 20:05 ET | [8-K](/filings/0000950170-25-038711.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-038711 |
| 2025-03-04 | 21:06 ET | [8-K](/filings/0001193125-25-045585.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-045585 |
| 2025-01-14 | 12:08 ET | [8-K](/filings/0001193125-25-005659.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005659 |
| 2024-12-09 | 21:45 ET | [8-K](/filings/0001193125-24-273467.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-273467 |
| 2024-11-06 | 21:15 ET | [10-Q](/filings/0000950170-24-122330.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122330 |
| 2024-11-06 | 21:10 ET | [8-K](/filings/0000950170-24-122300.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122300 |
| 2024-09-17 | 21:00 ET | [8-K](/filings/0000950170-24-107367.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-107367 |
| 2024-08-06 | 22:32 ET | [8-K](/filings/0001193125-24-194111.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-194111 |
| 2024-08-01 | 20:20 ET | [10-Q](/filings/0000950170-24-089320.md) | Quarterly report, period 2024-06-30 | 0000950170-24-089320 |
| 2024-08-01 | 20:10 ET | [8-K](/filings/0000950170-24-089278.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-089278 |
| 2024-06-13 | 00:46 ET | [8-K](/filings/0001193125-24-160146.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-160146 |
| 2024-06-03 | 20:35 ET | [8-K](/filings/0000950170-24-068050.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-068050 |
| 2024-05-08 | 20:16 ET | [10-Q](/filings/0000950170-24-055691.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055691 |
| 2024-05-08 | 20:10 ET | [8-K](/filings/0000950170-24-055656.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055656 |
| 2024-04-04 | 20:11 ET | [DEF 14A](/filings/0000950170-24-041805.md) | Proxy statement, period 2024-05-31 | 0000950170-24-041805 |
| 2024-03-11 | 12:00 ET | [8-K](/filings/0001193125-24-064353.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-064353 |
| 2024-02-27 | 21:15 ET | [10-K](/filings/0000950170-24-021161.md) | Annual report, period 2023-12-31 | 0000950170-24-021161 |
| 2024-02-27 | 21:10 ET | [8-K](/filings/0000950170-24-021130.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021130 |
| 2023-11-08 | 21:15 ET | [10-Q](/filings/0000950170-23-061144.md) | Quarterly report, period 2023-09-30 | 0000950170-23-061144 |
| 2023-11-08 | 21:10 ET | [8-K](/filings/0000950170-23-061110.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-061110 |
| 2023-09-01 | 20:12 ET | [8-K](/filings/0001193125-23-227647.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-227647 |
| 2023-08-02 | 20:15 ET | [10-Q](/filings/0000950170-23-037178.md) | Quarterly report, period 2023-06-30 | 0000950170-23-037178 |

Page 1 of 4. [Older](/companies/rgnx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.